Effects of hypertension and dyslipidemia on the decline in renal function

Hypertension

Volumn 26, Issue 4, 1995, Pages 670-675

  Mänttäri, Matti ^a   Tiula, Eero ^a   Alikoski, Tiina ^a   Manninen, Vesa ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

cholesterol; creatinine; kidney; lipoproteins, HDL cholesterol

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; DYSLIPIDEMIA; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0029166463     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.26.4.670     Document Type: Article

References (32)

1. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985;33: 278-285.
2. Lindeman RD, Tobin JD, Shock NW. Association between blood pressure and the rate of decline in renal function with age. Kidney Int. 1984;26:861-868.
3. Whelton PK, Klag MJ. Hypertension as a risk factor for renal disease: review of clinical and epidemiological evidence. Hypertension. 1989;13(suppl I):I-19-I-27.
4. Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, Schneider KA, on behalf of the Hypertension Detection and Follow-up Program Cooperative Group. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: results from the Hypertension Detection and Follow-up Program. Hypertension. 1989;13(suppl I):I-80-I-93.
5. Walker WG, Neaton JD, Cutler JA, Neuwirth R, Cohen JD, for the MRFIT Research Group. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial: racial and treatment effects. JAMA. 1992;268:3085-3091.
6. Perneger TV, Nieto J, Whelton PK, Klang MJ, Comstock GW, Szklo M. A prospective study of blood pressure and serum creatinine: results from the 'Clue' study and the ARIC study. JAMA. 1993;269:488-493.
7. Keane WF, Kasiske BL, O'Donnel MP. The role of lipids in progressive glomerular disease. Adv Exp Med Biol. 1987;223:81-87.
8. Diamond JR, Karnovsky MJ. Focal and segmentalglomerulosclerosis: analogies to atherosclerosis. Editorial review. Kidney Int. 1988;33:917-924.
9. Klahr S, Harris K. Role of dietary lipids and renal eicosanoids on the progression of renal disease. Kidney Int. 1989;36:27-31.
10. Kasiske BL, O'Donnel MP, Covardin W, Keane WF. Lipids and the kidney. Hypertension. 1990;15:443-450.
11. Moorhead JF. Lipids and the pathogeneis of kidney disease. Am J Kidney Dis. 1991;17(suppl 1):65-70.
12. Walli AK, Gröne E, Miller H-J, Thiery J, Seidel D. Role of lipoproteins in progressive renal disease. Am J Hypertens. 1993;6: 358S-366S.
13. Keane WF, Kasiske BL, O'Donnel MP, Kim Y. Hypertension, hyperlipidemia, and renal damage. Am J Kidney Dis. 1993;21(suppl 2):43-50.
14. Kasiske BL, Crosson JT. Renal disease in patients with massive obesity. Arch Intern Med. 1986;146:1105-1109.
15. Kasiske BL. Relationship between vascular disease and age-associated change in the human kidney. Kidney Int. 1987;31: 1153-1159.
16. Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, Mäenpää H, Mälkönen M, Mänttäri M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjöblom T, Nikkilä EA. The Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987;317: 1237-1245.
17. Mänttäri M, Elo O, Frick MH, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, Mäenpää H, Mälkönen M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjöblom T, Nikkilä EA. The Helsinki Heart Study: basic design and randomization procedure. Eur Heart J. 1987;8(suppl 1):1-29.
18. Frick MH, Manninen V, Huttunen JK, Heinonen OP, Tenkanen L, Mänttäri M. HDL-cholesterol as a risk factor in coronary heart disease: an update of the Helsinki Heart Study. Drugs. 1990; 40(suppl 1):7-14.
19. Mitch WE, Walser M, Buffington GA, Leman J Jr. A simple method of estimating progression of chronic renal failure. Lancet. 1976;2:1326-1328.
20. Rutheford WE, Blondin J, Miller JP, Greenwalt AS, Vavra JD. Chronic progressive renal disease: rate of change of serum creatinine concentration. Kidney Int. 1977;11:62-70.
21. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
22. Lindeman RD. Overview: renal physiology and pathophysiology of aging. Am J Kidney Dis. 1990;16:275-282.
23. Rowe JW, Reubin A, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol. 1976;31:155-163.
24. Levey AS, Berg RL, Gassman JJ, Hall PM, Walker WG, for the Modification of Diet in Renal Disease (MDRD) Study Group. Creatinine filtration, secretion and excretion during progressive renal disease. Kidney Int. 1989;36(suppl 27):S73-S80.
25. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
26. Diamond JR. Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int. 1991;39:S29-S34.
27. Diamond JR, Karnovsky MJ. A putative role of hypercholesterolemia in progressive glomerular injury. Annu Rev Med. 1992;43: 83-92.
28. Gröne H-J, Walli AK, Gröne E, Krämer A, Clemens MR, Seidel D. Receptor-mediated uptake of apo B and apo E rich lipoproteins by human glomerular epithelial cells. Kidney Int. 1990;37:1449-1459.
29. Tall AR. Metabolic and genetic control of HDL cholesterol levels. J Intern Med. 1992;231:661-668.
30. Gjone E. Familial lechitin:cholesterol acyltransferase deficiency - a new metabolic disease with renal involvement. Adv Nephrol. 1981; 10:167-185.
31. Danzinger RS, Tobin JD, Becker LC, Lakatta EE, Fleg JL. The age-associated decline in glomerular filtration in healthy normotensive volunteers: lack of relationship to cardiovascular performance. J Am Geriatr Soc. 1990;38:1127-1132.
32. Rosansky S, Hoover DR, King L, Gibson J. The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects. Arch Intern Med. 1990;150: 2073-2076.